小梁切除联合垂直巩膜条嵌顿术治疗晚期新生血管性青光眼的临床观察  

Treatment of neovascular glaucoma with trabeculectomy and sclerocleisis

作　　者：刘钢[1] 高保清[1] 

机构地区：[1]南京铁道医学院附属徐州医院眼科,221009

出　　处：《中国实用眼科杂志》2001年第6期437-439,共3页Chinese Journal of Practical Ophthalmology

摘　　要：目的 :评价小梁切除术联合垂直巩膜条切开返转嵌顿术 (术中用或不用丝裂霉素 )治疗晚期新生血管性青光眼的临床效果。方法 :采用巩膜瓣下咬切术联合垂直巩膜条切开返转嵌顿术 ,术中用或不用丝裂霉素治疗晚期新生血管性青光眼 2 7例 2 7眼。结果 :术后 6月内 ,2 7眼的眼压均正常 ;术后 1年时 ,眼压控制率达 94 % ( 16/ 17) ;术后 2年时 ,眼压控制达 81% ( 17/ 2 1)。无严重并发症。结论 :小梁切除术联合垂直巩膜条切开返转嵌顿术 (术中用或不用丝裂霉素 )是一种治疗晚期新生血管性青光眼有效方法。并对其机理、并发症和优点进行了扼要分析。Objective: To evaluate the clinical effects of trabeculectomy combined with sclerocleisis for advanced neovascular glaucoma, with or without mitomycin C in the operation. Methods: 27 eyes of 27 patients with advanced neovascular glaucoma were treated by trabeculectomy combined with sclerocleisis, with or without mitomycin C in the operation. Results: Postoperatively, the intraocular pressure of all patients were controlled at six months, the rate of controlled intraocular pressure was 94% (16/17) in one years, 81% (17/21) in two years. The postoperative complications were few and slight. Conclusions: The results suggested that trabeculectomy combined with sclerocleisis for advanced neovascular glaucoma, with or without mitomycin C in the operations was safe and effective.

关 键 词：新生血管性青光眼 小梁切除术 巩膜嵌顿术 丝裂霉素 

分 类 号：R775.9[医药卫生—眼科]